Liquid Genomics

Liquid Genomics is a biotech company focused on oncology diagnostics, specializing in liquid biopsy technologies for cancer detection and monitoring. Liquid biopsy approaches allow for non-invasive, blood-based cancer diagnostics, with potential applications in early detection, minimal residual disease (MRD) assessment, and monitoring response to therapy. While specific clinical results were not detailed in available sources, the technology is positioned as a tool for both clinical and research use in oncology. No commercial diagnostic products were listed, suggesting development-stage activity, but the company is active in the European biotech ecosystem as of its founding year[2].